These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 12687033

  • 1. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D, Ito S, Rowsell V, Shear NH.
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
    Robertson EE, Rankin GO.
    Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renal nucleoside transporters: physiological and clinical implications.
    Elwi AN, Damaraju VL, Baldwin SA, Young JD, Sawyer MB, Cass CE.
    Biochem Cell Biol; 2006 Dec; 84(6):844-58. PubMed ID: 17215872
    [Abstract] [Full Text] [Related]

  • 7. Effects of renal failure on drug transport and metabolism.
    Sun H, Frassetto L, Benet LZ.
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [Abstract] [Full Text] [Related]

  • 8. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
    Feng B, LaPerle JL, Chang G, Varma MV.
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic implications of renal anionic drug transporters.
    Masereeuw R, Russel FG.
    Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
    [Abstract] [Full Text] [Related]

  • 10. Transporters and renal drug elimination.
    Lee W, Kim RB.
    Annu Rev Pharmacol Toxicol; 2004 May; 44():137-66. PubMed ID: 14744242
    [Abstract] [Full Text] [Related]

  • 11. Drug secretion systems in renal tubular cells: functional models and molecular identity.
    Ito S.
    Pediatr Nephrol; 1999 Nov; 13(9):980-8. PubMed ID: 10603161
    [Abstract] [Full Text] [Related]

  • 12. Membrane transport function in primary cultures of human proximal tubular cells.
    Lash LH, Putt DA, Cai H.
    Toxicology; 2006 Dec 07; 228(2-3):200-18. PubMed ID: 16997449
    [Abstract] [Full Text] [Related]

  • 13. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
    Mandíková J, Volková M, Pávek P, Česnek M, Janeba Z, Kubíček V, Trejtnar F.
    Toxicology; 2013 Sep 15; 311(3):135-46. PubMed ID: 23856525
    [Abstract] [Full Text] [Related]

  • 14. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
    Nadai M, Kato M, Yoshizumi H, Kimura M, Kurono S, Abe F, Saito H, Hasegawa T.
    Life Sci; 2007 Sep 22; 81(15):1175-82. PubMed ID: 17897683
    [Abstract] [Full Text] [Related]

  • 15. Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.
    Leung S, Bendayan R.
    Can J Physiol Pharmacol; 1999 Aug 22; 77(8):625-30. PubMed ID: 10543726
    [Abstract] [Full Text] [Related]

  • 16. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U.
    J Pharm Pharmacol; 2007 Nov 22; 59(11):1463-71. PubMed ID: 17976256
    [Abstract] [Full Text] [Related]

  • 17. Drug transporters relevant to HIV therapy.
    Thomas SA.
    J HIV Ther; 2004 Nov 22; 9(4):92-6. PubMed ID: 15731741
    [Abstract] [Full Text] [Related]

  • 18. Organic anion transporter (Slc22a) family members as mediators of toxicity.
    Sweet DH.
    Toxicol Appl Pharmacol; 2005 May 01; 204(3):198-215. PubMed ID: 15845414
    [Abstract] [Full Text] [Related]

  • 19. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
    Watanabe T, Kusuhara H, Watanabe T, Debori Y, Maeda K, Kondo T, Nakayama H, Horita S, Ogilvie BW, Parkinson A, Hu Z, Sugiyama Y.
    Drug Metab Dispos; 2011 Jun 01; 39(6):1031-8. PubMed ID: 21383204
    [Abstract] [Full Text] [Related]

  • 20. Cellular and molecular aspects of drug transport in the kidney.
    Inui KI, Masuda S, Saito H.
    Kidney Int; 2000 Sep 01; 58(3):944-58. PubMed ID: 10972658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.